Literature DB >> 14999707

Chronic hepatitis B: update of recommendations.

Anna S F Lok1, Brian J McMahon.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14999707     DOI： 10.1002/hep.20110

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  104 in total

1.  Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.

Authors:  Jorge Méndez-Navarro; Kathleen E Corey; Hui Zheng; Lydia L Barlow; Jae Young Jang; Wenyu Lin; Hong Zhao; Run-Xuan Shao; Steven L McAfee; Raymond T Chung
Journal:  Liver Int       Date:  2010-08-25       Impact factor: 5.828

Review 2.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 3.  Predicting survival in hepatitis B.

Authors:  M Sherman
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 4.  Peginterferon-alpha-2a (40kD): a review of its use in the management of patients with chronic hepatitis B.

Authors:  Gayle W Robins; Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level.

Authors:  Tomoko Kurihara; Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Tatsuo Kanda; Shigenobu Kawai; Hiromitsu Saisho
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.

Authors:  Xiao-Jian Zhou; Barbara A Fielman; Deborah M Lloyd; George C Chao; Nathaniel A Brown
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 7.  Management of patients with HBeAg-negative chronic hepatitis B.

Authors:  Nripen Saikia; Rupjyoti Talukdar; Subhasish Mazumder; Sudeep Khanna; Rakesh Tandon
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

8.  Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.

Authors:  Jung Woo Shin; Neung Hwa Park; Seok Won Jung; Byung Chul Kim; Sung Ho Kwon; Jae Serk Park; In Du Jeong; Sung-Jo Bang; Do Ha Kim
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

9.  Clinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patients.

Authors:  Ma Teresa Pérez-Rodríguez; Bernardo Sopeña; Manuel Crespo; Alberto Rivera; Teresa González del Blanco; Antonio Ocampo; César Martínez-Vázquez
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

10.  Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.

Authors:  Sofia A Pereira; Umbelina Caixas; Teresa Branco; Isabel Germano; Fátima Lampreia; Ana L Papoila; Emília C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2008-06-09       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.